IBDEI0C0 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5312,1,5,0)
 ;;=5^Tattoo
 ;;^UTILITY(U,$J,358.3,5312,2)
 ;;=^303313
 ;;^UTILITY(U,$J,358.3,5313,0)
 ;;=448.9^^25^322^2
 ;;^UTILITY(U,$J,358.3,5313,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5313,1,2,0)
 ;;=2^448.9
 ;;^UTILITY(U,$J,358.3,5313,1,5,0)
 ;;=5^Telangiectasia
 ;;^UTILITY(U,$J,358.3,5313,2)
 ;;=^87263
 ;;^UTILITY(U,$J,358.3,5314,0)
 ;;=312.39^^25^322^3
 ;;^UTILITY(U,$J,358.3,5314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5314,1,2,0)
 ;;=2^312.39
 ;;^UTILITY(U,$J,358.3,5314,1,5,0)
 ;;=5^Trichotillomania
 ;;^UTILITY(U,$J,358.3,5314,2)
 ;;=^87511
 ;;^UTILITY(U,$J,358.3,5315,0)
 ;;=704.02^^25^322^4
 ;;^UTILITY(U,$J,358.3,5315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5315,1,2,0)
 ;;=2^704.02
 ;;^UTILITY(U,$J,358.3,5315,1,5,0)
 ;;=5^Telogen Effluvium
 ;;^UTILITY(U,$J,358.3,5315,2)
 ;;=^295751
 ;;^UTILITY(U,$J,358.3,5316,0)
 ;;=V82.0^^25^323^1
 ;;^UTILITY(U,$J,358.3,5316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5316,1,2,0)
 ;;=2^V82.0
 ;;^UTILITY(U,$J,358.3,5316,1,5,0)
 ;;=5^Spec Scr for Skin Cond
 ;;^UTILITY(U,$J,358.3,5316,2)
 ;;=^295694
 ;;^UTILITY(U,$J,358.3,5317,0)
 ;;=V76.43^^25^323^2
 ;;^UTILITY(U,$J,358.3,5317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5317,1,2,0)
 ;;=2^V76.43
 ;;^UTILITY(U,$J,358.3,5317,1,5,0)
 ;;=5^Screen for Malignant Skin Neoplasm
 ;;^UTILITY(U,$J,358.3,5317,2)
 ;;=^295657
 ;;^UTILITY(U,$J,358.3,5318,0)
 ;;=173.00^^25^324^1
 ;;^UTILITY(U,$J,358.3,5318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5318,1,2,0)
 ;;=2^173.00
 ;;^UTILITY(U,$J,358.3,5318,1,5,0)
 ;;=5^Malig Neopl Lip NOS
 ;;^UTILITY(U,$J,358.3,5318,2)
 ;;=^340596
 ;;^UTILITY(U,$J,358.3,5319,0)
 ;;=173.01^^25^324^2
 ;;^UTILITY(U,$J,358.3,5319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5319,1,2,0)
 ;;=2^173.01
 ;;^UTILITY(U,$J,358.3,5319,1,5,0)
 ;;=5^BCC of skin of lip
 ;;^UTILITY(U,$J,358.3,5319,2)
 ;;=^340464
 ;;^UTILITY(U,$J,358.3,5320,0)
 ;;=173.02^^25^324^3
 ;;^UTILITY(U,$J,358.3,5320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5320,1,2,0)
 ;;=2^173.02
 ;;^UTILITY(U,$J,358.3,5320,1,5,0)
 ;;=5^SCC of skin of lip
 ;;^UTILITY(U,$J,358.3,5320,2)
 ;;=^340465
 ;;^UTILITY(U,$J,358.3,5321,0)
 ;;=173.09^^25^324^4
 ;;^UTILITY(U,$J,358.3,5321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5321,1,2,0)
 ;;=2^173.09
 ;;^UTILITY(U,$J,358.3,5321,1,5,0)
 ;;=5^Other specified neoplasm of lip
 ;;^UTILITY(U,$J,358.3,5321,2)
 ;;=^340466
 ;;^UTILITY(U,$J,358.3,5322,0)
 ;;=173.10^^25^324^5
 ;;^UTILITY(U,$J,358.3,5322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5322,1,2,0)
 ;;=2^173.10
 ;;^UTILITY(U,$J,358.3,5322,1,5,0)
 ;;=5^Malig neoplasm of eyelid NOS
 ;;^UTILITY(U,$J,358.3,5322,2)
 ;;=^340597
 ;;^UTILITY(U,$J,358.3,5323,0)
 ;;=173.11^^25^324^6
 ;;^UTILITY(U,$J,358.3,5323,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5323,1,2,0)
 ;;=2^173.11
 ;;^UTILITY(U,$J,358.3,5323,1,5,0)
 ;;=5^BCC of skin of eyelid/canthus
 ;;^UTILITY(U,$J,358.3,5323,2)
 ;;=^340467
 ;;^UTILITY(U,$J,358.3,5324,0)
 ;;=173.12^^25^324^7
 ;;^UTILITY(U,$J,358.3,5324,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5324,1,2,0)
 ;;=2^173.12
 ;;^UTILITY(U,$J,358.3,5324,1,5,0)
 ;;=5^SCC of skin of eyelid/canthus
 ;;^UTILITY(U,$J,358.3,5324,2)
 ;;=^340468
 ;;^UTILITY(U,$J,358.3,5325,0)
 ;;=173.19^^25^324^8
 ;;^UTILITY(U,$J,358.3,5325,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5325,1,2,0)
 ;;=2^173.19
 ;;^UTILITY(U,$J,358.3,5325,1,5,0)
 ;;=5^Other specified neoplasm eyelid
 ;;^UTILITY(U,$J,358.3,5325,2)
 ;;=^340469
 ;;^UTILITY(U,$J,358.3,5326,0)
 ;;=173.20^^25^324^9
 ;;^UTILITY(U,$J,358.3,5326,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5326,1,2,0)
 ;;=2^173.20
 ;;
 ;;$END ROU IBDEI0C0
